<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04249388</url>
  </required_header>
  <id_info>
    <org_study_id>19072886</org_study_id>
    <nct_id>NCT04249388</nct_id>
  </id_info>
  <brief_title>Characteristics of People With Advanced Chronic Obstructive Pulmonary Disease (COPD) - A Multicenter Study</brief_title>
  <acronym>REPORT</acronym>
  <official_title>Rethink Pulmonary Rehabilitation (REPORT Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Bispebjerg and Frederiksberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hillerod Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herlev and Gentofte Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Bispebjerg and Frederiksberg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary rehabilitation (PR) is a cornerstone of care for people with COPD. There is robust
      evidence that PR improves exercise capacity, enhances health-related quality of life (QoL)
      and reduces healthcare utilization. PR is strongly recommended in guidelines for COPD
      management. Despite the compelling evidence for its benefits, PR is delivered to less than
      30% of people with COPD. Access is particularly challenging, an especially for those with the
      most progressed disease stages.

      We recently completed a randomized clinical trial, showing that approximately 1.100 patients
      annually are offered conventional hospital-based PR during routine consultations in the
      Capital Region of Denmark, but at least 700 patients declines participation.

      No major cohort studies have been published from people with severe and advanced COPD who opt
      out of traditional pulmonary rehabilitation. By establishing such cohort study, objective and
      qualitative knowledge from assessments and patient interviews is collected in patients we
      have very limited access to and knowledge of. Additionally, the collected data will give a
      deeper insight and understanding and possibly enable us to design new delivery models to be
      tested in proper study designs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective This cohort study aims to describe and understand differences and similarities in
      characteristics among people with severe and advanced COPD who opt-in or opt out of PR
      services.

      The study includes data from: socio-demographic, anthropometric, physical (function,
      activity, muscle strength, balance) characteristics as well as self-reported symptoms of
      anxiety, depression, fatigue, pain, lung symptoms, quality of life, sleep-quality, mortality,
      hospitaladmissions, length of stay and qualitative patient interviews.

      Data from our completed trial study (NCT02667171) will be used as the opt-in PR comparison
      cohort.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COPD Assessment Test (CAT)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in points. Lower score indicates improvement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6-Minute Walk Test Distance (6MWD)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes i meters. High is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in point. Low score is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euro-Qol (EQ5D)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in Visual analogue scale (VAS). Higher VAS is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Pain Inventory (BPI)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in points. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Fatigue Inventory (MFI-20)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassesment)</time_frame>
    <description>Observation of changes in points. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Physical Performance Battery (SPPB)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in point. High is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand-Grip Strength (JAMAR)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in kilo. High is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 seconds sit-to-stand test (30sec-STS)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in repetitions. High is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in point. Low score is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospital admissions (respiratory and all-cause)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in actual numbers. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital admissions (respiratory and all-cause)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in days. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Out-patient visits</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in actual number. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality (respiratory and all-cause)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassesment)</time_frame>
    <description>Observation of changes as number of deaths. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go Test</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment)</time_frame>
    <description>Observation of changes in seconds. Low is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity level (ActivPAL)</measure>
    <time_frame>baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) - Worn by the patients around the clock for 5 days</time_frame>
    <description>Observation of changes in steps per day. High is better</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Decliners of Pulmonary Rehabilitation</arm_group_label>
    <description>No intervention, just observation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention, just observation</intervention_name>
    <description>No Intervention, just observation</description>
    <arm_group_label>Decliners of Pulmonary Rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a prospective observational study of patients with COPD who declines participation
        in a conventional out-patient hospital-based PR program.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of COPD defined as a ratio of forced expiratory volume at one
             second (FEV1) to forced vital capacity &lt; 0.70

          -  FEV1 &lt;50%, corresponding to severe or very severe COPD

          -  Symptoms equivalent to the Medical Research Council (MRC) from 2 to 5

          -  Declines to participate in a conventional out-patient hospital-based PR program

        Exclusion Criteria:

          -  Concurrent participation in or recent completion of pulmonary rehabilitation within
             the last twelve months.

          -  Dementia/ Cognitive impairment or uncontrolled psychiatric illness,

          -  An impaired hearing and / or vision which causes the instructions in the assessment is
             not understood.

          -  language difficulties which causes inability to follow instruction or complete patient
             reported outcome measures (PROM.)

          -  Any comorbidity that are contraindicated to the assesment protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Charlotte Suppli Ulrik, MD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>Hvidovre University Hospital, Respiratory Department and Research Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henrik Hansen, PhD</last_name>
    <phone>+45 28946780</phone>
    <email>henrik.hansen.09@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nina Godtfredsen, MD, PhD</last_name>
    <email>Nina.Skavlan.Godtfredsen@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bispebjerg and Frederiksberg University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen North West</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisbeth Oestergaard, RN</last_name>
      <email>Lisbeth.Marie.Oestergaard@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Hanne Ehlers, Lead RN</last_name>
      <email>hanne.dybdal.ehlers@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Therese Lapperre, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisbeth Oestergaard, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hanne Ehlers, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amager and Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <state>Danmark</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrik Hansen, PhD</last_name>
      <email>henrik.hansen.09@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Nina Godtfredsen, MD, PhD</last_name>
      <email>Nina.Skavlan.Godtfredsen@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Henrik Hansen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nina Godtfredsen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Suppli Ulrik, MD, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gentofte and Herlev University Hospital</name>
      <address>
        <city>Gentofte</city>
        <state>Hellerup</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torgny Wilcke, MD, PhD</last_name>
      <email>t.wilcke@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mette Rosenberg, RN</last_name>
      <email>Mette.Rosenberg@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Torgny Wilcje, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nordsjaelland University Hospital</name>
      <address>
        <city>Hillerød</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Berrill, RN</last_name>
      <email>Anja.Berrill@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Stig Mølsted, PhD</last_name>
      <email>Stig.Moelsted@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Stig Mølsted, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anja Berrill, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 28, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Henrik Hansen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Proposal for data use should be addressed to Henrik.hansen.09@regionh.dk
Data access in Denmark are under very strict juristic data protection law.
Any possible access or sharing demands a part application to
Danish Data Protection Agency,
Ethics Committee of the Capital Region
National Health Data Authorities.
Only if the applications are approved data will be considered available for sharing. The authors will not be able to support this process and a prolonged process must be expected.</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>unresolved</ipd_time_frame>
    <ipd_access_criteria>Please read plan description</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

